IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease
- 1 October 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (7) , 2433-2435
- https://doi.org/10.1182/blood-2005-04-1597
Abstract
Interleukin-2 (IL-2) and IL-15 are structurally related cytokines that share receptor components but display markedly different effects in multiple in vivo model systems. Here we demonstrate that IL-15 but not IL-2 exacerbates xenogeneic graft-versus-host disease (X-GVHD) in severe combined immunodeficient murine recipients of human peripheral-blood lymphocytes (hu-PBL-SCID). Treatment of hu-PBL-SCID mice with IL-15 resulted in rapid fatality, lymphocytic infiltrations in the liver, lung, and spleen consistent with X-GVHD, and a marked expansion of human CD4+ and CD8+ T cells compared with controls. Depletion of human T cells in vivo abrogated the lethality of IL-15 treatment. To our knowledge, these data are the first to demonstrate in vivo activation and expansion of human T lymphocytes in response to IL-15 with concomitant exacerbation of human T-cell-mediated X-GVHD. (Blood. 2005;106:2433-2435)Keywords
This publication has 29 references indexed in Scilit:
- Anti–human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodiesBlood, 2005
- Donor-derived IL-15 is critical for acute allogeneic graft-versus-host diseaseBlood, 2005
- Dendritic cells generated in the presence of GM‐CSF plus IL‐15 prime potent CD8+ Tc1 responses in vivoEuropean Journal of Immunology, 2003
- A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- γc-/- double-mutant miceBlood, 2003
- Generalized autoimmune disease in interleukin‐2‐deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cellsEuropean Journal of Immunology, 1995
- A HUMAN MODEL OF XENOGENEIC GRAFT-VERSUS-HOST DISEASE IN SCID MICE ENGRAFTED WITH HUMAN PERIPHERAL BLOOD LYMPHOCYTESTransplantation, 1995
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994
- Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice.The Journal of Experimental Medicine, 1993
- ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATIONTransplantation, 1990
- Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice.The Journal of Experimental Medicine, 1989